Regulation of Extracellular Phospholipase A2Activity: Implications for Inflammatory Diseases
- 1 April 1992
- journal article
- review article
- Published by Mary Ann Liebert Inc in DNA and Cell Biology
- Vol. 11 (3) , 233-243
- https://doi.org/10.1089/dna.1992.11.233
Abstract
Phospholipases A2 (PLA2s; E.C.3.1.1.4) are a family of esterases that are involved in myriads of physiological and pathological processes. The involvement of these enzymes, especially the extracellular PLA2s, in the generation of proinflammatory lipid mediators makes them a very important target for investigation. These PLA2s have been suggested to be involved in the pathogenesis of several human inflammatory diseases. Thus, delineating the mechanism(s) of regulation of the activity of these enzymes may provide a better understanding of the pathophysiology of these diseases and allow the rational design and development of novel therapeutic agents. In this article, we provide a brief description of PLA2s in general with a special emphasis on extracellular enzymes, their mechanism(s) of action, and possible role in the pathogenesis of inflammatory diseases. Additionally, we describe: (i) a novel mechanism of activation of extracellular PLA2s by transglutaminases and (ii) the development of one class of antiinflammatory agents, antiflammins, derived from the active site structure of endogenous PLA2-inhibitory proteins.Keywords
This publication has 47 references indexed in Scilit:
- Inhibition of pancreatic phospholipase A2 activity by uteroglobin and antiflammin peptides: Possible mechanism of actionLife Sciences, 1991
- A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAPCell, 1991
- Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions.The Journal of Experimental Medicine, 1990
- Anti-inflammatory effects of vasocortin and nonapeptide fragments of uteroglobin and lipocortin I (antiflammins)Inflammation Research, 1990
- Novel peptides derived from a region of local homology between uteroglobin and lipocortin-1 inhibit platelet aggregation and secretionBiochemical and Biophysical Research Communications, 1989
- A phospholipase A2 hydrolyzing arachidonoyl‐phospholipids in mouse peritonea macrophagesFEBS Letters, 1989
- Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- A simple method for displaying the hydropathic character of a proteinJournal of Molecular Biology, 1982
- The release of phospholipase A2 from aggregated platelets and stimulated macrophages of sheepLife Sciences, 1980
- Selective release of archidonic acid from the phospholipids of human platelets in response to thrombin.Journal of Clinical Investigation, 1977